Patient Capital Management’s Farfetch Limited Class A Ordinary Shares FTCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,916,449
Closed -$41.8M 47
2023
Q2
$41.8M Buy
6,916,449
+5,929,649
+601% +$28.6M 2.32% 25
2023
Q1
$4.85M Sell
986,800
-94,300
-9% -$512K 2.16% 25
2022
Q4
$5.11M Buy
1,081,100
+318,100
+42% +$2.22M 2.48% 20
2022
Q3
$5.68M Buy
763,000
+153,000
+25% +$1.36M 2.84% 14
2022
Q2
$4.37M Buy
610,000
+173,200
+40% +$1.77M 1.93% 26
2022
Q1
$6.6M Buy
436,800
+178,400
+69% +$3.45M 2.24% 21
2021
Q4
$8.64M Buy
+258,400
New +$9.5M 2.49% 14

Other funds holding FTCH

Patient Capital Management's FTCH Position: Q3 2023 in Review

Patient Capital Management sold out of Farfetch Limited Class A Ordinary Shares (FTCH) in Q3 2023, closing a stake of 6,916,449 shares — an estimated $41.8M sold.

Patient Capital Management first reported a position in FTCH in Q4 2021 and held it in 7 quarters. The position peaked at $41.8M in Q2 2023. 175 funds tracked by Wall St. Rank hold FTCH as of Q3 2023.

  • Patient Capital Management reported no remaining Farfetch Limited Class A Ordinary Shares position as of Q3 2023 after selling out during the quarter.
  • Patient Capital Management sold 6,916,449 Farfetch Limited Class A Ordinary Shares shares in Q3 2023, an estimated $41.8M.
  • Patient Capital Management first reported a position in Farfetch Limited Class A Ordinary Shares in Q4 2021 and held it in 7 quarters.
  • Patient Capital Management's Farfetch Limited Class A Ordinary Shares position peaked at $41.8M in Q2 2023.
  • 175 funds tracked by Wall St. Rank held Farfetch Limited Class A Ordinary Shares as of Q3 2023.

Based on Patient Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.